Core point 1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream 2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates; Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries; Third, under the theme of security for a long time, energy security, self contro...
7
2
2
Report
Upncoming1841
:
my top pick of the beneficiary will be the Macau casino and trip.com
Fosun Pharma’s Q3 net profit increased by 41.62% year-on-year, and a total of 9.7 million doses of the mRNA new crown vaccine Fubitai® were administered $FOSUN PHARMA (02196.HK)$Fosun Pharma (02196.HK) yesterday disclosed the third quarterly report data, Q3 company revenue was 10.095 billion yuan, a year-on-year increase of 25.03%; net profit was 1.082 billion yuan, a year-on-year increase of 41.62%. The growth of Fosun Pharma’s performance is due to alleviation of the pressure of centralized procurement and price reduction of stock varieties. According to the announcement, as of October 24, Fosun Pharma’s Fubitai (mRNA Covid-19 vaccine) has been vaccinated in Hong Kong, Macau and Taiwan over 9.7 million. Agent. Article excerpted from the U.S. Stock Intelligence Agency
$FOSUN PHARMA (02196.HK)$Musk: The future of medicine is mRNA. Basically you can cure everything with mRNA, it's like a computer program that you can program to do whatever you need to do. You can actually turn into a butterfly. We added fosun Pharmaceutical today. Because I want to be a butterfly
Shanghai Fosun Pharmaceutical Stock Forum
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...
$Sinovac Biotech (SVA.US)$ $FOSUN PHARMA (02196.HK)$ $Shanghai Fosun Pharmaceutical (600196.SH)$ $CanSino Biologics Inc. (688185.SH)$ $CANSINOBIO (06185.HK)$ $Walvax Biotechnology (300142.SZ)$ $Chongqing Zhifei Biological Products (300122.SZ)$
$FOSUN PHARMA (02196.HK)$ Fosun Pharma (02196.HK) yesterday disclosed the third quarterly report data, Q3 company revenue was 10.095 billion yuan, a year-on-year increase of 25.03%; net profit was 1.082 billion yuan, a year-on-year increase of 41.62%.
The growth of Fosun Pharma’s performance is due to alleviation of the pressure of centralized procurement and price reduction of stock varieties. According to the announcement, as of October 24, Fosun Pharma’s Fubitai (mRNA Covid-19 vaccine) has been vaccinated in Hong Kong, Macau and Taiwan over 9.7 million. Agent.
Article excerpted from the U.S. Stock Intelligence Agency
We added fosun Pharmaceutical today.
Because I want to be a butterfly
No comment yet